10 20 30 40 50 60 70 80 1GJF - Header ----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----| Asymmetric UnitHEADER ANTAGONIST 11-MAY-01 1GJF
TITLE PEPTIDE ANTAGONIST OF IGFBP1, (I,I+7) COVALENTLY RESTRAINED ANALOG, TITLE 2 MINIMIZED AVERAGE STRUCTURE
COMPND MOL_ID: 1; COMPND 2 MOLECULE: IGFBP-1 ANTAGONIST; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES; COMPND 5 OTHER_DETAILS: (I,I+7) LOCKED HELIX VARIANT OF BP1-01
SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 OTHER_DETAILS: THE PEPTIDE WAS CHEMICALLY SYNTHESIZED. IT WAS SOURCE 4 DESIGNED FROM SEQUENCE SELECTED FROM A PHAGE DISPLAY LIBRARY.
KEYWDS COVALENTLY CONSTRAINED HELIX, ANTAGONIST
EXPDTA SOLUTION NMR
AUTHOR N.J.SKELTON,Y.M.CHEN,N.DUBREE,C.QUAN,D.Y.JACKSON,A.G.COCHRAN,K.ZOBEL, AUTHOR 2 K.DESHAYES,M.BACA,M.T.PISABARRO,H.B.LOWMAN
REVDAT 3 13-JUL-11 1GJF 1 VERSN REVDAT 2 24-FEB-09 1GJF 1 VERSN REVDAT 1 30-MAY-01 1GJF 0
JRNL AUTH N.J.SKELTON,Y.M.CHEN,N.DUBREE,C.QUAN,D.Y.JACKSON,A.COCHRAN, JRNL AUTH 2 K.ZOBEL,K.DESHAYES,M.BACA,M.T.PISABARRO,H.B.LOWMAN JRNL TITL STRUCTURE-FUNCTION ANALYSIS OF A PHAGE DISPLAY-DERIVED JRNL TITL 2 PEPTIDE THAT BINDS TO INSULIN-LIKE GROWTH FACTOR BINDING JRNL TITL 3 PROTEIN 1. JRNL REF BIOCHEMISTRY V. 40 8487 2001 JRNL REFN ISSN 0006-2960 JRNL PMID 11456486 JRNL DOI 10.1021/BI0103866
REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH H.B.LOWMAN,Y.M.CHEN,N.J.SKELTON,D.L.MORTENSEN,E.E.TOMLINSON, REMARK 1 AUTH 2 M.D.SADICK,I.C.ROBINSON,R.G.CLARK REMARK 1 TITL MOLECULAR MIMICS OF INSULIN-LIKE GROWTH FACTOR 1 (IGF-1) FOR REMARK 1 TITL 2 INHIBITING IGF-1: IGF-BINDING PROTEIN INTERACTIONS REMARK 1 REF BIOCHEMISTRY V. 37 8870 1998 REMARK 1 REFN ISSN 0006-2960 REMARK 1 DOI 10.1021/BI980426E
REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE.
REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : DGII 970, DISCOVER 970 REMARK 3 AUTHORS : HAVEL (DGII), MSI (DISCOVER) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: THE STRUCTURE WAS DETEMINED ON THE REMARK 3 BASIS OF 138 NOE DISTANCE RESTRAINTS AND 11 DIHEDRAL ANGLE REMARK 3 RESTRAINTS. THE RESULTING ENSEMBLE HAD NO RESTRAINT VIOLATIONS REMARK 3 GREATER THAN 0.07 ANGSTROMS OR 1.4 DEG. THE MEAN RESTRAINT REMARK 3 VIOLATION ENERGY WAS 0.04 +/- 0.03 KCAL/MOL.
REMARK 4 REMARK 4 1GJF COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 16-MAY-01. REMARK 100 THE RCSB ID CODE IS RCSB001581.
REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 303; 303 REMARK 210 PH : 5.0; 5.0 REMARK 210 IONIC STRENGTH : 0; 0 REMARK 210 PRESSURE : 1 ATM; 1 ATM REMARK 210 SAMPLE CONTENTS : 5 MM PEPTIDE; 5 MM PEPTIDE REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D-ROESY; DQF-COSY; COSY-35 REMARK 210 SPECTROMETER FIELD STRENGTH : 500 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : FELIX 970 REMARK 210 METHOD USED : RESTRAINED MOLECULAR DYNAMICS REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : NULL REMARK 210 CONFORMERS, NUMBER SUBMITTED : 1 REMARK 210 CONFORMERS, SELECTION CRITERIA : NULL REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : NULL REMARK 210 REMARK 210 REMARK: THIS STRUCTURE WAS DETERMINED USING STANDARD 2D REMARK 210 HOMONUCLEAR TECHNIQUES.
REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS.
REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA.
REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 6 -51.62 -124.13 REMARK 500 REMARK 500 REMARK: NULL
REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE LNK A 17
REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1IMW RELATED DB: PDB REMARK 900 PEPTIDE ANTAGONIST OF IGFBP1 REMARK 900 RELATED ID: 1IN2 RELATED DB: PDB REMARK 900 PEPTIDE ANTAGONIST OF IGFBP1, (I,I+7) COVALENTLY RESTRAINED REMARK 900 ANALOG REMARK 900 RELATED ID: 1IN3 RELATED DB: PDB REMARK 900 PEPTIDE ANTAGONIST OF IGFBP1, (I,I+8) COVALENTLY RESTRAINED REMARK 900 ANALOG REMARK 900 RELATED ID: 1GJE RELATED DB: PDB REMARK 900 PEPTIDE ANTAGONIST OF IGFBP-1, MINIMIZED AVERAGE STRUCTURE REMARK 900 RELATED ID: 1GJG RELATED DB: PDB REMARK 900 PEPTIDE ANTAGONIST OF IGFBP1, (I,I+8) COVALENTLY RESTRAINED REMARK 900 ANALOG, MINIMIZED AVERAGE STRUCTURE
DBREF 1GJF A 1 16 PDB 1GJF 1GJF 1 16
SEQRES 1 A 16 ACE ARG ALA GLY PRO LEU GLN TRP LEU ALA GLU LYS TYR SEQRES 2 A 16 GLN GLY NH2
HET ACE A 1 6 HET NH2 A 16 3 HET LNK A 17 15
HETNAM ACE ACETYL GROUP HETNAM NH2 AMINO GROUP HETNAM LNK PENTANE
FORMUL 1 ACE C2 H4 O FORMUL 1 NH2 H2 N FORMUL 2 LNK C5 H12
HELIX 1 1 LEU A 6 GLY A 15 1 10
LINK NE2 GLN A 7 C1 LNK A 17 1555 1555 1.45 LINK NE2 GLN A 14 C5 LNK A 17 1555 1555 1.46 LINK C ACE A 1 N ARG A 2 1555 1555 1.34 LINK C GLY A 15 N NH2 A 16 1555 1555 1.33
SITE 1 AC1 3 GLN A 7 ALA A 10 GLN A 14
CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 1.000000 0.000000 0.000000 0.00000
SCALE2 0.000000 1.000000 0.000000 0.00000
SCALE3 0.000000 0.000000 1.000000 0.00000